Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 471-477

  Agnelli, Giancarlo ^a   Becattini, Cecilia ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

HUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; TIME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84904533958     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.471     Document Type: Review

References (0)